Cancer incidence and mortality in Iran.

BACKGROUND Cancer is the third main cause of death in Iran. This report was provided for explaining cancer incidence and mortality. PATIENTS AND METHODS The National Cancer Registry reports from 2003 to 2006, population-based cancer registry reports from five provinces in 2006 and National Death Registry reports from 1999 to 2004 have been applied in this report. RESULTS The age-standardized incidence rate of cancers was 98 and 110 per 100,000 among females and males. The male to female standard ratio was 1.12. The most common cancer among women and men was breast cancer (24) and stomach cancer (15), respectively. The estimated mortality rate for cancer was 41.1 and 65 per 100,000 for females and males in 2004. CONCLUSION The current low cancer incidence rates in Iran might be due to lack of national cancer screening programs for prostate, colorectal or breast cancer, a consequence of incomplete registration as well as incomplete diagnosis of cancer patients; it is expected that it will rise dramatically in the future because of anticipated increase in life expectancy and westernized lifestyle. The first priorities for health policy makers should be developing, establishing and implementing national cancer control; or else, the health system could not respond to the demands regarding to diagnosis, treatment and palliation for these patients in the future.

[1]  O. M. Jensen,et al.  Cancer Registration: Principles and Methods , 1991 .

[2]  K. Katanoda,et al.  Comparison of time trends in cancer incidence (1973-1997) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vol. IV-VIII. , 2007, Japanese journal of clinical oncology.

[3]  A. Alamolhoda,et al.  Implementation of Comprehensive National Cancer Control Program in Iran: an experience in a developing country. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  D. Qiu,et al.  Comparison of time trends in liver cancer incidence (1973-1997) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vol. IV-VIII. , 2007, Japanese journal of clinical oncology.

[5]  Xiaolong Fan,et al.  Temporal trends of esophageal cancer during 1995–2004 in Nanao Island, an extremely high-risk area in China , 2006, European Journal of Epidemiology.

[6]  R. Malekzadeh,et al.  Cancer occurrence in Ardabil: Results of a population‐based Cancer Registry from Iran , 2003, International journal of cancer.

[7]  M. Mohagheghi,et al.  Clustering of childhood cancer in the inner city of Tehran metropolitan area: a GIS-based analysis. , 2007, International journal of hygiene and environmental health.

[8]  N. Kayani,et al.  Cancer profile of Hyderabad, Pakistan 1998-2002. , 2005, Asian Pacific journal of cancer prevention : APJCP.

[9]  G. Meijer GLOBOCAN 1: Cancer Incidence and Mortality Worldwide. , 2000 .

[10]  H. Sriplung,et al.  Cancer incidence in Thailand, 1995-1997. , 2005, Asian Pacific journal of cancer prevention : APJCP.

[11]  M. Al-Tarawneh,et al.  Cancer incidence in Jordan, 1996-2005. , 2010, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[12]  N. Kayani,et al.  Cancer profile of Larkana, Pakistan (2000-2002). , 2006, Asian Pacific journal of cancer prevention : APJCP.

[13]  M. Malek,et al.  Cancer occurrence in Semnan Province, Iran: results of a population-based cancer registry. , 2005, Asian Pacific journal of cancer prevention : APJCP.

[14]  Jacques Ferlay,et al.  Cancer incidence in five continents. , 1976, IARC scientific publications.

[15]  R. Malekzadeh,et al.  Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance. , 2006, Cancer detection and prevention.